TRCT
BCDA icon

Tower Research Capital (TRC)’s BioCardia BCDA Stock Holding History

Tower Research Capital (TRC)’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6K Sell
2,978
-316
-10% -$395 ﹤0.01% 4292
2025
Q4 		$4.12K Buy
3,294
+3,197
+3,296% +$4.34K ﹤0.01% 4257
2025
Q3 		$125 Buy
+97
New +$189 ﹤0.01% 5096
2025
Q1 		– Sell
-535
Closed -$1.17K – 5196
2024
Q4 		$1.17K Sell
535
-747
-58% -$1.75K ﹤0.01% 5075
2024
Q3 		$4K Sell
1,282
-1,754
-58% -$5.05K ﹤0.01% 4711
2024
Q2 		$9.02K Buy
3,036
+3,015
+14,357% +$15.1K ﹤0.01% 4298
2024
Q1 		$127 Buy
21
+5
+31% +$36 ﹤0.01% 5624
2023
Q4 		$159 Buy
+16
New +$130 ﹤0.01% 5663
2023
Q3 		– Sell
-10
Closed -$382 – 5946
2023
Q2 		$382 Sell
10
-130
-93% -$4.01K ﹤0.01% 5666
2023
Q1 		$4K Buy
140
+67
+92% +$2.22K ﹤0.01% 5046
2022
Q4 		$2K Sell
73
-87
-54% -$2.47K ﹤0.01% 5328
2022
Q3 		$5K Buy
160
+109
+214% +$2.82K ﹤0.01% 5124
2022
Q2 		$1K Buy
+51
New +$1.22K ﹤0.01% 5733
2022
Q1 		– Sell
-147
Closed -$4K – 6084
2021
Q4 		$4K Buy
+147
New +$5.39K ﹤0.01% 5278
2021
Q2 		– Sell
-213
Closed -$14K – 5464
2021
Q1 		$14K Sell
213
-455
-68% -$28.4K ﹤0.01% 4143
2020
Q4 		$35K Buy
+668
New +$26.7K ﹤0.01% 3444
2020
Q3 		– Sell
-173
Closed -$6K – 4815
2020
Q2 		$6K Buy
+173
New +$9.37K ﹤0.01% 4198
2020
Q1 		– Sell
-154
Closed -$8K – 3050
2019
Q4 		$8K Buy
154
+21
+16% +$1.23K ﹤0.01% 2429
2019
Q3 		$7K Buy
+133
New +$9.54K ﹤0.01% 3125

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Tower Research Capital (TRC)'s BCDA Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its BioCardia (BCDA) stake by 9.6% in Q1 2026, selling an estimated $395 and leaving 2,978 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4292.

Tower Research Capital (TRC) first reported a position in BCDA in Q3 2019 and has held it in 19 quarters since. The position peaked at $35K in Q4 2020. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Tower Research Capital (TRC) held 2,978 shares of BioCardia worth $3.6K as of Q1 2026.
  • Tower Research Capital (TRC) sold 316 BioCardia shares in Q1 2026, an estimated $395.
  • BioCardia made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4292 holding.
  • Tower Research Capital (TRC) first reported a position in BioCardia in Q3 2019 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s BioCardia position peaked at $35K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.